BSE Healthcare PB	6.7
BSE Healthcare PE	40.3
BSE Healthcare DIV	0.5
BSE Healthcare EPS	1,109.4

BSE Healthcare Corporate Filings & Announcements

Latest corporate announcements and filings from BSE Healthcare on BSE

Load latest

Alembic Pharmaceuticals Ltd.

01 Apr 2025

951.95

1.51%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for injection, 40 mg/vial (Single Dose Vial)

pdf

J B Chemicals & Pharmaceuticals Ltd.

01 Apr 2025

1709.70

-1.12%

SAST

JB Chemicals & Pharmaceuticals Ltd - 506943 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for abrdn Asia Ltd

pdf

Sigachi Industries Ltd.

01 Apr 2025

31.52

0.35%

SAST

Sigachi Industries Ltd - 543389 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2025 for Dharani Devi C

pdf

Yatharth Hospital & Trauma Care Services Ltd.

01 Apr 2025

798.05

1.77%

SAST

Yatharth Hospital & Trauma Care Services Ltd - 543950 - Disclosures under Reg. 31(1) and 31(2) …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 29, 2025 for Dr. Kapil Kumar

pdf

SMS Pharmaceuticals Ltd.

01 Apr 2025

268.03

7.85%

SAST

SMS Pharmaceuticals Ltd - 532815 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 28, 2025 for Hima Bindu Potluri

pdf

SMS Pharmaceuticals Ltd.

01 Apr 2025

268.03

7.85%

SAST

SMS Pharmaceuticals Ltd - 532815 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 28, 2025 for Potluri Laboratories Pvt Ltd

pdf

SMS Pharmaceuticals Ltd.

01 Apr 2025

268.03

7.85%

SAST

SMS Pharmaceuticals Ltd - 532815 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 28, 2025 for Potluri Infra Projects LLP

pdf

Abbott India Ltd.

01 Apr 2025

31255.00

2.04%

Company Update

Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Senior Management Personnel.

pdf

Wockhardt Ltd.

01 Apr 2025

1559.90

4.43%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, please find enclosed Press Release - "Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with ZaynichTM (Zidebactam/Cefepime, WCK 5222)

pdf